微博
加入微博一起分享新鲜事
登录
|
注册
140
Are we doing better? Impact of treatment paradigm change on neovascular age-related macular degeneration treatment outcomes over the past decade. A big data analysis. https://denaxaslab.org/publication/schwartz-2021-we/
请登录并选择要私信的好友
300
Are we doing better? Impact of treatment paradigm change on neovascular age-related macular degeneration treatment outcomes over the past decade. A big data analysis. https://denaxaslab.org/publication/schwartz-2021-we/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候